Pharmacokinetic Parameters Clinical Uses Type 2 diabetes mellitus Obesity management Cardiovascular risk reduction in patients with diabetes Nonalcoholic fatty liver disease (off-label, investigational) Adverse Effects Nausea and vomiting Diarrhea Pancreatitis (rare) Thyroid C-cell tumors (rodent studies) Injection site reactions (if injectable) Comparative Analysis MCQs GLP-1 receptor agonists primarily act on: a) Alpha cells b) Beta cells c) Delta cells d) Hepatocytes Answer: b) Beta cells These drugs increase insulin secretion in a: a) Continuous manner b) Glucose-independent way c) Glucose-dependent way d) Inhibited state Answer: c) Glucose-dependent way Which of the following is a known adverse effect of GLP-1 agonists
Immunoprecipitation (IP): Add a specific antibody against the bait protein to the pre-cleared lysate and incubate to promote binding
Studies using gene array analysis have reported that GHK-Cu modulates the expression of hundreds of human genes including genes involved in tissue remodelling, inflammation regulation, DNA repair, antioxidant defence, and cellular metabolism making it a uniquely broad-spectrum research tool for studying peptide-driven gene regulation
"Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell): review by two specialists is required for initiating valproate but not for male patients already taking valproate"
Unlike this, an almost complete counteraction was noted when NaBPC157 was coadministered with haloperidol